Revalesio Corporation
13 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis (NCT02988297) | Revalesio Corporation | 2026-10-01 |
| Safety of RNS60 in Large Vessel Occlusion Stroke Patients Undergoing Endovascular Thrombectomy (NCT04693715) | Revalesio Corporation | 2021-07-07 |
Track Revalesio Corporation automatically
Every clearance here is in the API, with alerts when new ones post.